Home
Zydus Lifesciences Limited
Press Release Mar 16 2025
Business
Mar 16 2025
5 min read

Press Release Mar 16 2025

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 16, 2025, titled "Zydus receives final approval from USFDA for Eluxadoline Tablets, 75 mg and 100 mg".

View Attachment

Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren